Results 61 to 70 of about 5,453 (193)

Expression and Roles of Antimicrobial Peptides in Innate Defense of Airway Mucosa: Potential Implication in Cystic Fibrosis

open access: yesFrontiers in Immunology, 2020
The treatment of respiratory infections is associated with the dissemination of antibiotic resistance in the community and clinical settings. Development of new antibiotics is notoriously costly and slow; therefore, alternative strategies are needed ...
Regina Geitani   +8 more
doaj   +1 more source

Les indications à une retransplantation pulmonaire : une approche selon la méthode DELPHI [PDF]

open access: yes, 2012
1) Etat des connaissances : Actuellement, les indications à la transplantation pulmonaire sont bien décrites et validées. Par contre, lors d'une retransplantation, les résultats restent encore discutés : la retransplantation pulmonaire reste la seule ...
Dabboubi, N.
core  

A Importância das Associações de Fibrose Cística na Vida dos Pacientes e Familiares

open access: yesClinical and Biomedical Research, 2011
Na organização da sociedade moderna as associações filantrópicas tornaram-se importantes no cenário mundial.No Brasil após a fundação da ABRAM várias associações regionais se estruturaram para defender os pacientes com Fibrose Cística.No RGS, duas ...
Cleci Furian Müller, Elizabete Backes
doaj  

Isoniazid‐Dihydropyrimidinone Molecular Hybrids: Design, Synthesis, Antitubercular Activity, and Cytotoxicity Investigations with Computational Validation

open access: yesChemMedChem, Volume 20, Issue 11, June 2, 2025.
Antitubercular evaluation of a novel library of isoniazid‐dihydropyrimidinone molecular hybrids (8a–8n) discloses a potent compound with MIC = 0.39μg mL−1 against M. tuberculosis mc26230. Cytotoxicity, stability, and in silico studies, including molecular docking and ADME/T (absorption, distribution, metabolism, excretion, and toxicity) analysis ...
Gobind Kumar   +10 more
wiley   +1 more source

One year of ETI reduces lung bacterial colonisation in adults with cystic fibrosis

open access: yesScientific Reports
The triple combination elexacaftor-tezacaftor-ivacaftor (ETI) has provided unprecedented clinical benefits for people with cystic fibrosis (pwCF) and drastically transformed the outcome of this disease.
Lucile Mianowski   +7 more
doaj   +1 more source

Une politique de santé "a priori". Le dépistage néonatal de la mucoviscidose en Bretagne

open access: yes, 2004
Le dépistage néonatal de la mucoviscidose (DNM), qui fait l'objet d'un débat, au plan international, sur son opportunité, a été décidé officiellement en 2002 en France.
Vailly, Joëlle
core   +2 more sources

Émergence de nouveaux champignons pathogènes en médecine : revue générale [PDF]

open access: yes, 2009
RésuméAu cours des 20 dernières années, l’incidence des infections fongiques, tant superficielles que profondes, a augmenté de façon considérable. Ces pathologies surviennent le plus souvent chez des patients fragilisés (transplantations d’organes ...
D. Chabasse, J.P. Bouchara, M. Pihet
core   +4 more sources

Infecção Respiratória na Fibrose Cística e Tratamento

open access: yesClinical and Biomedical Research, 2011
Fibrose Cística é uma doença multissistêmica e complexa, que exige tratamento contínuo. A doença pulmonar é o principal determinante da sua evolução.
Anneliese Hoffmann   +1 more
doaj  

Development and validation of the Cystic Fibrosis Decisional Balance for Physical Activity scale (CF-DB-PA)

open access: yesBMC Pulmonary Medicine, 2021
Background People with cystic fibrosis (pwCF) derive several physiological and psychological benefits from regular physical activity (PA), but the practice is lower than recommended.
Valentine Filleul   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy